Skip to main navigation Skip to search Skip to main content

A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection

  • Liverpool School of Tropical Medicine
  • Edinburgh Napier University
  • University of Liverpool
  • University of Verona
  • University College Dublin

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

M. tuberculosis and HIV-1 syndemic interactions are a major global health concern. Despite the clinical significance of co-infection, our understanding of the cellular pathophysiology and the therapeutic pharmacodynamic impact of co-infection is limited. Here, we use single-round infectious HIV-1 pseudo-typed viral-particles expressing GFP alongside M. tuberculosis expressing mCherry to study pathogenesis and treatment. We report that HIV-1 infection inhibited intracellular replication of M. tuberculosis and demonstrate the therapeutic activity of antiviral treatment (efavirenz) and antimicrobial treatment (rifampicin). The described method could be applied for detailed mechanistic studies to inform the development of novel treatment strategies.

Original languageEnglish
Pages (from-to)708-713
Number of pages6
JournalJournal of Infectious Diseases
Volume227
Issue number5
DOIs
Publication statusPublished - 20 Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • coinfection
  • drug screening
  • HIV-1
  • Mycobacterium tuberculosis
  • tuberculosis

Themes

  • Maternal, Neonatal, Sexual and Reproductive Health
  • Tuberculosis and Antimicrobial Resistance

Fingerprint

Dive into the research topics of 'A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection'. Together they form a unique fingerprint.

Cite this